BridgeMD
New treatment option for Cigarette Smoking-Related Carcinoma
Official title Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
ClinicalTrials.gov ID: NCT06816459
What this study is testing
- What it's testing
- This clinical trial tests how well current daily smoking adults can identify flavors of cigarettes. Menthol cigarettes account for 31 percent of cigarettes sold in the United States.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 55. Healthy volunteers may be eligible.
You may be able to join if
- Aged 21-55 years old
- Current daily smoker of factory-made menthol cigarettes
- General good health (assessed by self-rated health item)
- Completion of Brief Smell Identification Test (B-SIT) with no identification of deficits
You likely can't join if
- Daily concurrent use of other tobacco products (e.g., e-cigarettes, cigars, smokeless tobacco)
- Known allergies to mint (peppermint, spearmint), menthol
- Self-reported olfactory or taste deficits
- Pregnant or nursing participants, as indicated by self-report
- History of medications known to interfere with sense of smell
- Positive diagnosis of coronavirus 2019 (COVID-19) within 10 days of enrollment
See the full eligibility criteria
- Aged 21-55 years old
- Current daily smoker of factory-made menthol cigarettes
- General good health (assessed by self-rated health item)
- Completion of Brief Smell Identification Test (B-SIT) with no identification of deficits
- Daily concurrent use of other tobacco products (e.g., e-cigarettes, cigars, smokeless tobacco)
- Known allergies to mint (peppermint, spearmint), menthol
- Self-reported olfactory or taste deficits
- Pregnant or nursing participants, as indicated by self-report
- History of medications known to interfere with sense of smell
- Positive diagnosis of coronavirus 2019 (COVID-19) within 10 days of enrollment
- Current upper respiratory infection or sinus congestion (e.g., cold, flu, seasonal allergies) (by self report)
The study team makes the final eligibility decision.
Where it's taking place
- Buffalo, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.